Inflammation level in type 2 diabetes is associated with dietary advanced glycation end products, Mediterranean diet adherence and oxidative balance score: A pathway analysis

Basit Öğe Kaydı
dc.authoridYARDIMCI, Hulya/0000-0002-2664-4176
dc.contributor.authorDemirer, Busra
dc.contributor.authorYardimci, Hulya
dc.contributor.authorBasmaz, Seda Erem
dc.date.accessioned2024-09-29T15:57:30Z
dc.date.available2024-09-29T15:57:30Z
dc.date.issued2023
dc.departmentKarabük Üniversitesien_US
dc.description.abstractAims: The aim of this study was to evaluate the effects of dietary advanced glycation end products (dAGE) intake, Mediterranean diet adherence screener (MEDAS), and oxidative balance score (OBS) on inflammation among individuals with type 2 diabetes. Methods: The study was conducted with 96 adults (aged between 32 and 64 years) with type 2 diabetes. The average daily dAGE intakes, energy and macronutrient intakes of the participants were taken with the three-day food consumption recording method. OBS and MEDAS score was used. At the same time, routine blood lipids, HbA1c, fasting blood glucose and inflammation marker C-reactive protein (CRP) were measured. Results: Dietary AGE intake was associated with fasting blood glucose, HbA1c, CRP and blood pressures (p < 0.01). The relationship between OBS and dAGE intake was significant (8 = -0.36; 95 % Cl = -0.500, -0.220; p < 0.001). MEDAS has a negative and statistically significant effect on dAGE intake (8 = -0.56; 95 % Cl = -0.696, -0.444; p < 0.001). There was a significant and positive effect of dAGE on CRP when other variables (MEDAS, OBS) affecting dAGE were also included in the analysis (8 = 0.79; 95 % CI = 0.664, 0.917; p < 0.001). Conclusions: Our findings may have important implications for explaining the development of inflammation in type 2 diabetes patients with high dAGE intake.en_US
dc.identifier.doi10.1016/j.jdiacomp.2022.108354
dc.identifier.issn1056-8727
dc.identifier.issn1873-460X
dc.identifier.issue1en_US
dc.identifier.pmid36493637en_US
dc.identifier.scopus2-s2.0-85143913259en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.urihttps://doi.org/10.1016/j.jdiacomp.2022.108354
dc.identifier.urihttps://hdl.handle.net/20.500.14619/4845
dc.identifier.volume37en_US
dc.identifier.wosWOS:000903976200001en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofJournal of Diabetes and Its Complicationsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectDietary advanced glycation end productsen_US
dc.subjectDiabetesen_US
dc.subjectInflammationen_US
dc.subjectMediterranean dieten_US
dc.titleInflammation level in type 2 diabetes is associated with dietary advanced glycation end products, Mediterranean diet adherence and oxidative balance score: A pathway analysisen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu